You are here

Annexon, Inc.

Company Information
Address
180 Kimball Way Ste 200 Fl 2
South San Francisco, CA 94080-6218
United States



Information

UEI: KVPFLBUEA8C7

# of Employees: 6


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. Development of novel inhibitors of C1q for the treatment of Neurodegenerative diseases

    Amount: $1,213,915.00

    DESCRIPTION provided by applicant Alzheimerandapos s disease AD is the most common cause of dementia in the aging population and is a serious unmet medical social and economic problem worldwide ...

    SBIRPhase II2016Department of Health and Human Services National Institutes of Health
  2. Development of novel inhibitors of complement for the treatment of Alzheimer's Di

    Amount: $167,000.00

    DESCRIPTION (provided by applicant): The loss of synapses is an early hallmark of Alzheimer's disease (AD) preceding neuronal loss and predicting cognitive deficit. Dr Ben Bares, Annexon co-found ...

    SBIRPhase I2012Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government